Vinge has advised Deutsche Börse, one of the world’s largest operators of marketplaces for securities trading, in the Swedish part of the acquisition of a majority holding amounting to approximately 80% of Institutional Shareholder Services Inc., a leading provider of ESG data, steering and analysis to investors.
Carl von Linnékliniken Group is a leading fertility treatment clinic based in Uppsala offering various treatments such as IVF, IUI and gamete donation.
Vinge has advised VEF Ltd, an investment company whose Swedish Depositary Receipts (“SDR”) are listed on Nasdaq First North, in connection with a directed share issue whereby VEF receives approximately SEK 522 million in issue proceeds.
PointSharp provides security solutions which enable enterprises to secure the login of their users to all their applications through e.g. multi-factor authentication, with a simplified user experience. PointSharp serves more than 220 customers globally.
Vinge has advised Pareto Securities in its capacity as Sole Manager and Bookrunner in connection with a directed share issue in the pharmaceutical company Xbrane Bipharma, whereby Xbrane Biopharma receives gross proceeds of approximately SEK 200 million.
Diagnostiskt Centrum Hud, the leading provider of medical dermatology services in Sweden, partnered with Bridgepoint Growth to further support the company’s expansion.
Vinge assisted the STRAX group in refinancing and the entering into a facilities agreement with Proventus Capital Partners IV (“Proventus”) as lender in the total amount of EUR 30 million.